Kimura Yasuharu, Naitou Yuki, Wanibuchi Fumikazu, Yamaguchi Tokio
Pharmacology Research Labs, Drug Discovery Research, Astellas Pharma Inc, Tsukuba-Shi, Ibaraki, Japan.
Eur J Pharmacol. 2008 Jul 28;589(1-3):157-62. doi: 10.1016/j.ejphar.2008.05.022. Epub 2008 May 24.
5-Hydroxytryptamine (5-HT), dopamine, oxytocin and melanocortin pathways are known to be involved in the induction of penile erections in rats. Although a dopamine-oxytocin-5-HT link in the central nervous system has been suggested to be important to the control of penile erections, the 5-HT receptor subtype that mediates dopamine-oxytocin-5-HT action and the relationship between the dopamine-oxytocin-5-HT pathway and melanocortin pathway have not been fully elucidated. In this study, in order to clarify these matters, we examined the effects of a selective 5-HT(2B)/5-HT(2C) receptors antagonist, 1-(1-methylindol-5-yl)-3-(3-pyridyl)urea (SB200646) and a selective 5-HT(2C) receptor antagonist, 6-chloro-5-methyl-1-[6-(2-methylpyridin-3-yloxy) pyridin-3-yl carbamoyl] indoline (SB242084) on penile erections induced by a dopamine receptor agonist, 10, 11-dihydroxyaporphine (apomorphine), oxytocin, or a melanocortin receptor agonist, melanotan-II (MT-II) in rats. SB200646 at 10 mg/kg and SB242084 at 3 mg/kg, these doses which completely antagonize penile erections induced by 5-HT(2C) receptor agonists, m-chlorophenylpiperazine (mCPP) and (S)-2-(7-ethyl-1H-furo[2,3-g]indazol-1-yl)-1-methylethylamine (YM348), significantly inhibited penile erections elicited by apomorphine, oxytocin or MT-II. In addition, in order to clarify further the suggestion that the 5-HT pathway projecting from medulla oblongata to lumbosacral spinal site and lumbosacral 5-HT(2C) receptor are involved in the induction of penile erection, we also examined the proerectile effect of YM348 in spinal and a 5-HT depletor, p-chlorophenyl alanine (pCPA)-treated rats. YM348 induced intracavernous pressure increase in spinal and pCPA-treated rats as well as normal rats. These results suggest that 5-HT(2C) receptor in lumbosacral spinal sites mediates not only dopamine-oxytocin-5-HT action but melanocortin action on penile erections, and that the 5-HT pathway is located downstream from melanocortin pathway as well as the dopamine-oxytocin pathway.
已知5-羟色胺(5-HT)、多巴胺、催产素和黑皮质素途径参与大鼠阴茎勃起的诱导。尽管中枢神经系统中的多巴胺-催产素-5-HT联系被认为对阴茎勃起的控制很重要,但介导多巴胺-催产素-5-HT作用的5-HT受体亚型以及多巴胺-催产素-5-HT途径与黑皮质素途径之间的关系尚未完全阐明。在本研究中,为了阐明这些问题,我们研究了选择性5-HT(2B)/5-HT(2C)受体拮抗剂1-(1-甲基吲哚-5-基)-3-(3-吡啶基)脲(SB200646)和选择性5-HT(2C)受体拮抗剂6-氯-5-甲基-1-[6-(2-甲基吡啶-3-基氧基)吡啶-3-基氨基甲酰]吲哚啉(SB242084)对多巴胺受体激动剂10,11-二羟基阿朴吗啡(阿扑吗啡)、催产素或黑皮质素受体激动剂黑素细胞刺激素-II(MT-II)诱导的大鼠阴茎勃起的影响。10mg/kg的SB200646和3mg/kg的SB242084,这两个剂量能完全拮抗由5-HT(2C)受体激动剂间氯苯哌嗪(mCPP)和(S)-2-(7-乙基-1H-呋喃并[2,3-g]吲唑-1-基)-1-甲基乙胺(YM348)诱导的阴茎勃起,显著抑制阿扑吗啡、催产素或MT-II引起的阴茎勃起。此外,为了进一步阐明从延髓投射到腰骶脊髓部位的5-HT途径和腰骶部5-HT(2C)受体参与阴茎勃起诱导的观点,我们还研究了YM348对脊髓和5-羟色胺耗竭剂对氯苯丙氨酸(pCPA)处理的大鼠的促勃起作用。YM348在脊髓和pCPA处理的大鼠以及正常大鼠中均诱导海绵体内压升高。这些结果表明,腰骶脊髓部位的5-HT(2C)受体不仅介导多巴胺-催产素-5-HT作用,还介导黑皮质素对阴茎勃起的作用,并且5-HT途径位于黑皮质素途径以及多巴胺-催产素途径的下游。